Shilanski & Associates’s argenx ARGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,540
Closed -$424K – 114
2021
Q1
$424K Sell
1,540
-44
-3% -$13.9K 0.23% 73
2020
Q4
$466K Sell
1,584
-46
-3% -$12.6K 0.28% 67
2020
Q3
$428K Buy
1,630
+2
+0.1% +$481 0.29% 64
2020
Q2
$367K Buy
1,628
+101
+7% +$17.9K 0.27% 64
2020
Q1
$201K Buy
1,527
+39
+3% +$5.71K 0.2% 74
2019
Q4
$239K Buy
+1,488
New +$201K 0.18% 74
2019
Q3
– Sell
-1,518
Closed -$215K – 89
2019
Q2
$215K Buy
+1,518
New +$193K 0.17% 79

Other funds holding ARGX

Shilanski & Associates's ARGX Position: Q2 2021 in Review

Shilanski & Associates sold out of argenx (ARGX) in Q2 2021, closing a stake of 1,540 shares — an estimated $424K sold.

Shilanski & Associates first reported a position in ARGX in Q2 2019 and held it in 7 quarters. The position peaked at $466K in Q4 2020. 177 funds tracked by Wall St. Rank hold ARGX as of Q2 2021.

  • Shilanski & Associates reported no remaining argenx position as of Q2 2021 after selling out during the quarter.
  • Shilanski & Associates sold 1,540 argenx shares in Q2 2021, an estimated $424K.
  • Shilanski & Associates first reported a position in argenx in Q2 2019 and held it in 7 quarters.
  • Shilanski & Associates's argenx position peaked at $466K in Q4 2020.
  • 177 funds tracked by Wall St. Rank held argenx as of Q2 2021.

Based on Shilanski & Associates's 13F filing for Q2 2021, filed 13 Aug 2021.